NanoVibronix Shares Slide 10% Despite Patent Grant

(RTTNews) - NanoVibronix, Inc. (NAOV) fell 9.85 percent to $4.94 on Thursday, down $0.54, even after announcing a new U.S. patent. The company said the United States Patent and Trademark Office issued Patent No. 12,402,953 B2 to its subsidiary ENvue Medical Holdings. The patent covers a proprietary system that overlays electromagnetic navigation data onto real-time imaging methods such as X-ray, CT, ultrasound, and MRI. The stock opened at $5.46 and traded between $4.71 and $5.70, compared with a prior close of $5.48 on the Nasdaq. Trading volume reached 1.63 million shares, well above the average of 314,115. NanoVibronix shares are now trading at the bottom of their 52-week range of $4.71 to $162.50.